
    
      OUTLINE: Patients are randomized to 1 of 2 arms.

      ARM I: Beginning 7 days prior to transplant, patients receive Nozin via nasal single-use
      popswabs or single-use cotton tipped applicators and swab the inside of their nose two times
      daily (BID) up to 100 days after transplant.

      ARM II: Patients receive standard of care.

      After completion of study, patients are followed up every week for 6 weeks and then every
      alternate week until day 100.
    
  